A new study published in the European Heart Journal Open reveals the baseline characteristics of 300 heart failure patients enrolled in the AZIMUTH trial — using Healthentia, an EU-MDR-approved smartphone app, to transform real-world cardiac care. About the Trial Heart failure affects more than 64 million people worldwide, yet a persistent implementation gap...
At Healthentia, we are constantly expanding our ecosystem to bring clinically relevant data...
2025 has been a milestone year for Healthentia, one where scientific rigor, cutting-edge...
Healthentia has recently published two papers on the topic of COPD (Chronic Obstructive...
Healthentia by Innovation Sprint, together with partners from the iHelp consortium, has contributed to...
We have published a paper in the Journal of Medical Internet Research (JMIR), where we present...
A paper recently was published on the study design and Phase 1 results of the...
In the evolving landscape of digital health, understanding and supporting patient adherence to treatment remains...
Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires...
World Diabetes Day is an essential reminder of the global impact of diabetes. Especially...